Analysts Set ArcBest Co. (NASDAQ:ARCB) Target Price at $142.50
ArcBest Co. (NASDAQ:ARCB – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and nine have issued a buy recommendation on […]
More Stories
Caterpillar Inc. (NYSE:CAT) Shares Sold by Winthrop Advisory Group LLC
Winthrop Advisory Group LLC trimmed its stake in Caterpillar Inc. (NYSE:CAT – Free Report) by 2.4% during the first quarter,...
Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Drops By 30.9%
Apollomics, Inc. (NASDAQ:APLMW – Get Free Report) saw a significant decline in short interest in the month of June. As...
Applied Materials, Inc. (NASDAQ:AMAT) Shares Purchased by Physician Wealth Advisors Inc.
Physician Wealth Advisors Inc. grew its stake in shares of Applied Materials, Inc. (NASDAQ:AMAT – Free Report) by 3.2% in...
Bristol-Myers Squibb (NYSE:BMY) Stake Raised by New Mexico Educational Retirement Board
New Mexico Educational Retirement Board grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 15.9% during...
SPDR Gold Shares (NYSEARCA:GLD) Position Increased by Fox Hill Wealth Management
Fox Hill Wealth Management lifted its holdings in shares of SPDR Gold Shares (NYSEARCA:GLD – Free Report) by 1.1% during...
iShares Core U.S. Aggregate Bond ETF (NYSEARCA:AGG) Shares Acquired by Physician Wealth Advisors Inc.
Physician Wealth Advisors Inc. lifted its stake in shares of iShares Core U.S. Aggregate Bond ETF (NYSEARCA:AGG – Free Report)...